Abstract:Background Circulating monocytes are functionally heterogeneous and can be divided into classical (CMo), intermediate (IMo), and non-CMo/patrolling monocyte (PMo) subsets. CMo can differentiate into PMo through IMo. PMos have been shown to inhibit cancer metastasis but the role of IMo is unclear. To date, no strategy has been developed to inhibit cancer metastasis through enhancing PMo/IMo differentiation. Methods We screened multiple inflammatory cytokines/chemokines activity of modulating PMo/IMo associated cell markers expression using human monocyte in vitro culture system. We tested our candidate cytokine activity in vivo using multiple mice models. We identified critical key factors and cytokines for our candidate cytokine activity by using gene-knockout mice and neutralization antibodies. Results We identified IFN-γ as a candidate inflammatory cytokine in the regulation of human IMo/PMo marker expression. Our in vivo data demonstrated that IMo expansion was induced by short-term (3 days) IFN-γ treatment through increasing CMo-IMo differentiation and blocking IMo-PMo differentiation. The IMo induced by IFN-γ (IFN-IMo), but not IFN-γ activated CMo (IFN-CMo), inhibited cancer metastasis by 90%. Surprizing, the effect of IFN-γ is greater in PMo deficiency mice, indicating the effect of IFN-IMo is not mediated through further differentiation into PMo. We also found that IFN-IMos induced by short-term IFN-γ treatment robustly boosted NK cell expansion for threefold and promoted NK differentiation and function through IL-27 and CXCL9. Furthermore, we identified that FOXO1, a key molecule controlling cellular energy metabolism, mediated the effect of IFN-γ induced IL-27 expression, and that NR4A1, a key molecule controlling PMo differentiation and inhibiting cancer metastasis, inhibited the pro-NK cell and anti-metastasis activity of IFN-IMo by suppressing CXCL9 expression. Conclusions We have discovered the antimetastasis and pro-NK cell activity of IFN-IMo, identified FOXO1 as a key molecule for IFN-γ driven monocyte differentiation and function, and found NR4A1 as an inhibitory molecule for IFN-IMo activity. Our study has not only shown novel mechanisms for a classical antitumor cytokine but also provided potential target for developing superior monocytic cell therapy against cancer metastasis.

IFN-γ and STAT1 Arrest Monocyte Migration and Modulate RAC/CDC42 Pathways

Ifn-γ and stat 1 arrest monocyte migration and modulate rac / cdc 42 pathways 1

Interferon Gamma Inhibits CXCL8-Induced Proliferation and Migration of Pancreatic Cancer BxPC-3 Cell Line Via a RhoGDI2/Rac1/NF-κB Signaling Pathway.

Ifn-Gamma-Primed Macrophages Exhibit Increased Ccr2-Dependent Migration and Altered Ifn-Gamma Responses Mediated by Stat1

G-CSF Maintains Controlled Neutrophil Mobilization During Acute Inflammation by Negatively Regulating CXCR2 Signaling

Regulation of monocyte induced cell migration by the RNA binding protein, FXR1

Cannabinoid Receptor 2 Suppresses Leukocyte Inflammatory Migration by Modulating the JNK/c-Jun/Alox5 Pathway

Cxcr3 Expression on Cd34(+) Hemopoietic Progenitors Induced by Granulocyte-Macrophage Colony-Stimulating Factor: Ii. Signaling Pathways Involved

Investigation of fascin1, a marker of mature dendritic cells, reveals a New role for IL-6 signaling in chemotaxis

IFNγ induces epithelial reprogramming driving CXCL11-mediated T cell migration

Migration Inhibitory Factor Up-Regulates Vascular Cell Adhesion Molecule-1 and Intercellular Adhesion Molecule-1 Via Src, PI3 Kinase, and NFκB

Regulation of Human T-Lymphocyte Chemotaxis In-Vitro by T-Cell-Derived Cytokines Il-2, Ifn-Gamma, Il-4, Il-10, and Il-13

CXCR2-mediated tumor-associated neutrophil recruitment is regulated by IFN-β

A Monocyte-Orchestrated IFN-I-to-IL-4 Cytokine Axis Instigates Protumoral Macrophages and Thwarts Poly(I:C) Therapy.

IFNγ and GM-CSF control complementary differentiation programs in the monocyte-to-phagocyte transition during neuroinflammation

Endosomal Chemokine Receptor Signalosomes Regulate Central Mechanisms Underlying Cell Migration

Cross-regulation of Signaling Pathways by Interferon-γ: Implications for Immune Responses and Autoimmune Diseases

Intermediate monocytes induced by IFN-γ inhibit cancer metastasis by promoting NK cell activation through FOXO1 and interleukin-27

Effect of IFN-α on KC and LIX Expression: Role of STAT1 and Its Effect on Neutrophil Recruitment to the Spleen after Lipopolysaccharide Stimulation

CCR7 Chemokine Receptor-Inducible Lnc-Dpf3 Restrains Dendritic Cell Migration by Inhibiting HIF-1α-Mediated Glycolysis

Epigenetic Regulation of Inflammatory NF-κB Target Genes by IFN-γ via IRF1